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Abstract Stroke remains the third most important cause of
mortality in industrialized countries; this has prompted
research for improvements in both diagnostic and thera-
peutic strategies for patients with signs of acute cerebral
ischemia. Over the last decade, there has been a parallel in
progress in techniques in both diagnostic and therapeutic
options. While previously only used for excluding hemor-
rhage, imaging now has the possibility to detect ischemia,
vascular occlusion, as well as detect tissue at risk in one
setting. It should also allow to monitor treatment and
predict/exclude therapeutic complications. Parallel to
advances in magnetic resonance imaging of stroke, com-
puted tomography has improved immensely over the last
decade due to the development of CT scanners that are
faster and that allow to acquire studies such as CT
perfusion or CT angiography in a reliable way. CT can
detect many signs that might help us detect impending
signs of massive infarction, but we still lack the experience
to use these alone to prevent a patient from benefitting from
possible therapy.
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Introduction
Acute stroke is an important cause of morbidity and
mortality in all industrialized nations. For a long time, it
was considered a hopeless situation with at best the
prospect of lengthy rehabilitation periods for the affected
patients. However, due to an impressive investment in
energy during the decade of the brain in the 1990s, this
purely attentive attitude has now been overcome, and over
the last decade, thrombolysis has become an established
standard of care [1–6]. This has been due to the
simultaneous development of both new diagnostic and
therapeutic strategies that have changed completely our
vision of the disease.
According to the AHA guidelines, the first aim of global
assessment of a patient with suspected stroke is to exclude
another possible cause of symptoms (such as hemorrhage)
[7, 8] (Fig. 1).
Indeed, signs of acute neurological dysfunction referable
to stroke can be caused by a number of conditions. These
so-called stroke mimics can be caused by a number of
conditions such as epilepsy, brain tumors, or event
infections/inflammatory diseases of the central nervous
system. The aims of neuroimaging are manifold [9]: (1)
rule out hemorrhage (and also demonstrate its cause, hence
CT angiography, see below); (2) demonstrate the presence
of ischemia since the non-absence of hemorrhage is not
enough to make a diagnosis of stroke; (3) show the
presence of hemodynamically compromised tissue (tissue
at risk or penumbra); (4) demonstrate the underlying cause
(vascular occlusion or embolus, carotid stenosis, or even
cardiac source); in addition to this imaging must allow to
monitor treatment (demonstrate success by showing reper-
fusion or demonstrating failure and or complications such
as emboli or bleeding); and, finally, (6) to allow follow-up
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imaging that correlates well with clinical status. Where one
must be careful in the interpretation of these findings, be it
with CTor MRI, is that the concept of the ischemic penumbra
has evolved a lot since its original description and has moved
from one of thresholds in intracellular energies to one of
demonstrations of areas of relative hypoperfusion: While both
these concepts are intimately and ultimately related, they do
not represent the same concept, and it had been shown that
vessel recanalization by any means even if effective does not
always represent revascularization and a potential positive
effect on brain tissue.
The accepted time window for intravenous therapy has
now increased to 4.5 h. While in the acute setting nuclear
medicine techniques have moved to the background on the
stage of neuroimaging for the moment, we momentarily
rely on techniques such as magnetic resonance imaging and
computed tomography to image the brain for ischemia.
Imaging must of course not interfere with treatment
options. Depending on local availabilities, both modalities
may be equally used, but often, CT has remained the
workhorse of acute stroke imaging. Magnetic resonance
allows acquiring images of diffusion and perfusion that
have been proven useful in acute stroke [10–13]. While MR
is considered equivalent for the detection of hemorrhage
Fig. 1 Patient with hemorrhagic
stroke; there is a visible
hematoma in the basal ganglia
with edema. This is a left MCA
stroke with hemorrhagic
transformation
Fig. 2 Left-sided dense middle cerebral artery sign
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[14] and superior for ischemia [15], CT still remains at the
forefront. MRI will be clearly superior for the detection of
small cortical infarcts and for small lacunar lesions located
deep in the brain. However, for purposes of detecting large
lesions, CT still has a power of detection that is almost
equivalent in trained eyes.
Early signs The typical early signs that are looked for are
the dense artery sign at the level of any cerebral artery, loss
of gray/white matter differentiation, beginning hypodensity,
sulcal effacement, and mass effect that are all due to the
presence of beginning edema. These early CT signs have
been found alone or in combination to be present in up to
92% of cases [16]. Von Kummer et al. [17] also found that
early changes were often associated with poor outcome
especially if swelling was present. There has been found a
good inter-observer agreement for these signs [18].
The dense artery sign This represents visualization of the
thrombus on unenhanced CT in the affected vessel (Figs. 2,
Fig. 3 Left-sided dense MCA
sign (a). CT angiography shows
occlusion of the left M1 seg-
ment of the MCA (b), while
there is beginning left MCA
hypodensity (c) and severe
hypoperfusion (d)
Fig. 4 Hyperdense basilar
artery sign in a patient with
signs of brain stem dysfunction.
The unenhanced CT (a) shows
hyperdensity of the vessel with
no enhancement after contrast
administration (b). There is a
stop of the contrast column on
vertebral angiography (c) and
the posterior cerebral arteries are
not visible. After thrombolysis,
the vessel is no longer
hyperdense (d)
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3, 4, 5, and 6). It is present in 35% to 67% [19] and is
known to disappear after recanalization. The dense artery
sign has been associated with a poorer outcome in most
studies [20–23]. When such an occlusion is seen in a small
middle cerebral artery (MCA) branch, it is referred to as the
dot sign [24, 25]. False positives are known to occur in
cases with vascular calcification, patients with a high
hematocrit. This sign can be visible in any affected cerebral
artery. Von Kummer et al. [17] found it to have a 32%
positive predictive value (PPV) for fatal clinical outcome.
Brain swelling with sulcal effacement This is one of the
earlier signs that may appear and is due to the mass effect
caused by beginning water accumulation (Figs. 7 and 8). It
was found to be present in 38% of cases and to have a 70%
PPV for fatal outcome [17]. In a study of only 14 patients
where it was found to be isolated, it was, however, not
found to represent severe ischemic damage [26].
Hypodensity Brain density, or rather the presence of hypoen-
sity in the affected vascular territory, has been widely used as a
negative selection criterion for thrombolysis. Computed
tomography shows differences in tissue composition due to
the absorption of X-rays by the tissue. This is directly
influenced by water content. In acute stroke, there is the early
development of cytotoxic edema which, after a time, leads to
infarction. CT is able to differentiate gray from white matter
due to the slight differences in water content. The water
Fig. 5 Hyperdense right
posterior cerebral artery
(a, arrow). There is severe
hypoperfusion in the
right PCA territory
Fig. 6 Dot sign in the right
sylvian fissure (arrow)
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concentration in gray matter is normally of 85% and 75% in
the white matter. In acute stroke, as water accumulates, this
leads to a decrease in Hounsfield units [27] with visual
homogenization of brain tissue at first: This leads to the loss of
gray/white differentiation that leads to the disappearance of the
basal ganglia (Fig. 9), the cortical, and insular ribbons as well.
The method used is the one of the third of the affected
MCA territory: When a hypodensity is visible that affects one
third or more of the territory, this patient will show no benefit
of thrombolysis but an increase of having lethal hemorrhage
according to the European Cooperative Acute Stroke Study
(ECASS) criteria [28]. Prior, Von Kummer et al. [17] had
found that a hypodensity covering more than 50% of the
middle cerebral artery territory had an 85% PPV for fatal
outcome. Lev et al. [29] found that using variable window
settings could improve the detection of hypoattenuation.
CT perfusion imaging Perfusion imaging allows investigat-
ing the presence or absence of alterations in cerebral
perfusion in patients with suspected stroke [30–35] (Figs. 10
and 11). One drawback at the moment is that most scanners
still only offer coverage over a few slices corresponding to
a few centimeters instead of the whole brain; this does not
always allow evaluating exact perfusion deficit volumes if
they exceed the volume studied and also does not allow
investigating areas outside the area chosen. Brain perfusion
with MR has evolved into a whole brain method that allows
full coverage of the neurocranium; this is now possible with
a few select scanners either with extensive row numbers or
with special techniques. After having found that penumbral
thresholds could be determined by CT perfusion [36],
Schaefer et al. [37] found a high correlation between CT and
MR perfusion for the determination of the penumbra. There is,
Fig. 7 Sulcal effacement: On
the unenhanced CT, there is
sulcal effacement in the right
hemisphere (a); this is
associated with severe
hypoperfusion as seen on the
MTT maps (b, c). The
penumbra map shows
inhomogenous perfusion
(d); the angiogram shows
occlusion with
hypovascularization (e)
on the parenchymography
overview due to M1
occlusion (f)
Fig. 8 Patient with a right-sided
hand paresis: On CT, there is
slight sulcal effacement in the
left motor cortex (a); on
diffusion-weighted MRI, the
small cortical lesion
lights up (b)
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however, the trend for the development of CT perfusion
strategies covering more and more of the volume of the brain,
with scanners even achieving 320 slices, but these are at the
moment more prototypes. Also, the development of CT
perfusion techniques based on flat panel CT should allow
combining all axial imaging modalities (CT, CT angiography
(CTA), CT perfusion) with the interventional techniques in
order to facilitate and combine diagnostic and interventional
procedures in order to gain time.
Many CT manufacturers now provide automated or
semi-automated calculations of perfusion and penumbral
maps. While the perfusion maps are of use in the
management of therapeutic measures, the use of penumbra
maps has not been fully validated until now. We have found
that an easy way of estimating penumbra is the simple
subtraction of time to peak (TTP) area from mean transit
time (MTT) area of hypoperfusion; while this may not be
standard and may not be hemodynamically accurate, it does
function as a simple model to assess perfusion differences
[38]. While Wintermark et al. found that decision making
could be done as well with CT as with MRI in all cases but
one, this was not entirely supported by the findings of the
DIAS-2 Study where a difference in the decisions was
found based on CT perfusion or MR perfusion regarding
the delineation of the penumbra; this may, however, been
due also to technical and patient selection differences [39].
CT angiography Due to the development of faster multi-array
scanner, CTA can now cover a larger and larger area going
from the aortic arch or even the heart into the Circle of Willis
(Figs. 12 and 13). This allows for the complete all-in-one
approach that leads to a combined neuro-cardio-radiological
Fig. 9 Patient with left hemispheric stroke: The striatum on the left is
no longer clearly visible as on the right
Fig. 10 Patient with signs of
right hemispheric ischemia.
There is hypoperfusion with a
MTT-TTP “mismatch”
(a, b); on the unenhanced CT,
there is a small hypodensity
(c). After thrombolysis, we see
almost complete reperfusion
(d, e) and a small cortical
lesion on the CT (f)
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workup. The presence of more distal occlusions was
associated with better outcome [40].
Source images Some authors have advocated using the
source images of CTA acquisitions in the assessment of
infarction (Figs. 14, 15, and 16). While this gives an
improved visualization of the affected area, there is a
perfusion effect, and it should not be confused with acute
hypodensity. This was shown by both Schaefer and Rosenthal
[41, 42]: In vertebrobasilar occlusion, this hypoattenuation
was found to be the best predicted by Schaefer et al. [41] and
for MCA infarction by Rosenthal et al. [42]. Camargo et al.
[43] found them to be more sensitive than non-enhanced
images: 70% vs 48% sensitivity for detection. When applied
to the Alberta Stroke Program Early CT score, there is also
an improvement of determination of outcome when com-
Fig. 11 Patient with massive left hemispheric stroke but no penumbra: There is a match between MTT TTP and CBF maps; the penumbra map
shows almost no tissue at risk and only infarction. On the follow-up DWI, this large MCA infarction is confirmed
Fig. 12 Patient with left MCA
stroke: Unenhanced CT shows
left hyperdense MCA sign; on
angio-CT, there is non-
opacification of the same vessel
segment, seen better on the 3D
reconstructions and confirmed
by DSA
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pared to unenhanced images [44, 45]. Schwamm et al. [46]
also found that the hypoattenuation on CTA images could
improve prediction of post-therapeutic hemorrhage.
Prognostic signs on imaging Overall, the presence of
hypodensity of more than one third alone is considered a
negative prognostic sign. The remaining early signs are also
considered to some degree to be of unfavorable prognostic
value [16].
Time window Once there has been a decrease in blood flow
due to embolus or occlusion, the timeframe available to
Fig. 13 Patient with carotid
artery dissection: Reconstruc-
tion of the CTA shows a flame
signs, confirmed by DSA
Fig. 14 Seventy-two-year-old
female patient with right
hemispheric stroke. On the
unenhanced CT, there is slight
sulcal effacement and
ventricular asymmetry (a). This
is more apparent on the
angio-CT source images (b),
even more on the angio-CT
reconstructions (c). On DSA,
there was a
corresponding occlusion
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Fig. 15 Patient with signs of
right hemispheric stroke. The
thick reconstructions of the CTA
show the compromised better
visualized (a, b) than the axial
unenhanced slices (c, d)
Fig. 16 Patient with a left hemispheric cerebellar infarction. On the unenhanced CT, the lesion is almost not visible (a), whereas it becomes more
apparent on the thick slab reconstructions (b, c). The lesion is confirmed by MRI (c–h)
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treat is very short. Up until now, there was an agreement for
intravenous thrombolysis that this therapeutic window was
of 3 h for the MCA territory and longer for the posterior
circulation due to the collateralization of these territories.
ECASS 3 has recently shown that the time window has
now increased to 4.5 h [4]. While CT perfusion can monitor
the presence or not of revascularization, this technique
might be complemented by the use of transcranial Doppler
to follow the effect on revascularization. Also, if one is
beyond the timeframe for the accepted drugs, other
mechanical techniques might be added with benefit on
revascularization [47].
Reperfusion therapies Once it has been established that a
patient has a stroke and that he can be treated, imaging
should try to detect not only which cases are amenable to
treatment but also which ones should be used. While there
is no clear consensus, it is possible that density of the
thrombus will play a role. What is certain is that length of
the thrombus will play a role: A longer thrombi will
probably necessitate intravascular therapy. Vora et al. [48]
found that hemorrhagic infarctions were related to the CT
infarction, while parenchymal hematomas are associated
with the presence of tandem occlusions, hyperglycemia
among others, after treatment.
Follow-up imaging with CT Despite literature reporting
higher incidence of post-stroke hemorrhage, a retrospective
study of 91 patients showed only 3.6% of patients with
ischemic stroke to have hemorrhage [49]. After intra-
arterial thrombolysis, large hyperdense areas are often seen
on CT, and it is sometimes unclear whether this is blood,
contrast, or a mixture of both (Fig. 17). A recent study has
tried to provide answers to this burning question: Contrast
enhancement where the blood–brain barrier (BBB) is intact
leads to hemorrhage in 20–30%, whereas contrast extrav-
asation where the BBB is broken leads to hemorrhage in
almost 100% [50].
Conclusions
Computed tomography still has an important role to play in
the investigation of patients with signs suggestive of acute
cerebral ischemia. It still is more easy to use for the
detection of hemorrhage since most radiologists will not be
acquainted with the early MR appearance of hemorrhage.
The problem most clinicians are nowadays confronted with
when dealing with radiology, and this is especially true
when dealing with a disease such as stroke, is to quickly
provide a precise answer to a difficult question by using a
challenging technology. Computed tomography has
remained at the forefront of imaging in acute stroke because
it is slightly faster than for example MR, and patient
handling is simpler and more secure because there are no
concerns regarding claustrophobia and magnetic fields (the
patients must not be metal-free as they should be in MRI).
This is why it is the method that has been used up until now
within the scope of the major defining drug studies for
thrombolysis (ECASS) and is the method recommended by
most guidelines [51, 52]. While CT is the gold standard for
the clear-cut exclusion of hemorrhage, the use of the
remaining acute ischemic signs is lightly more open to
debate. Indeed, while most are known to be of negative
prognosis, they cannot be used alone to prevent a patient
from undergoing thrombolysis. The really established CT
criteria for thrombolysis are on the one hand the presence
or absence of hemorrhage and on the other hand the
presence of a large tissular hypodensity: Both these signs
have been demonstrated to be of use to exclude patients
from potential harmful effects of therapy. This is of course
true for the treatment that we are currently using now with
tissue plasminogen activator. However, the potential emer-
gence of new drugs or even the switch toward mechanical
Fig. 17 Patient having undergone intra-arterial thrombolysis for a
left-hemispheric stroke. The CT shows hyperdensity in the left basal
ganglia corresponding to contrast
Table 1 Overview of studies comparing CT and MR in acute stroke.
Lansberg et al. (2000): DWI + in all cases, CT not
Barber et al.: DW (1999)I 100%, CT 75%
Mullins et al.: DWI: sensitivity: 97.3%, CT: 61.9%
Fiebach et al. (2002).: DWI: accuracy: 91%, CT: 61%
Fiebach et al. (2001): DWI: 100%, CT 71%
Chalela et al. (2007): MRI: 46%; CT: 10%; at 3 hours: MRI: 46%;
CT: 7%
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thrombectomy and vessel recanalization therapies may
render some of these signs (hypodensity) of less use for
the future.
Also, there has been great progress in scanner hardware,
and these new CT units now allow scanning the whole
brain in a few seconds. Perfusion coverage is also
improved, and while a few prototypes allow whole brain
coverage, unfortunately, most scanners can only cover a
few slices. In many centers, CT has remained the standard
for all acute stroke investigations. However, there is a shift
of paradigm in some centers due to some specific
advantages of MRI. Indeed, MRI will detect better small
cortical or lacunar infarctions. This certainly explains why
in most studies (Table 1), MR with diffusion imaging is
seen as a clearly superior method [53–57]. Whatever
method is chosen, it is important that certain standards be
followed that are being established at the moment [58].
However, many of the early signs that are known can be
seen on very close inspection of scans by experienced
readers. While more difficult to interpret than the light bulb
effect we see on diffusion-weighted imaging (DWI) [59],
these signs are often seen and can help in the workup. Also,
despite the fact that from known literature MRI should be
equivalent in the detection of hemorrhage, CT is still the
gold standard for the exclusion of hemorrhage in the acute
phase, which is the main aim of radiology. For more
complicated studies about the behavior of the ischemic
lesion related to ischemia or neuroprotective drugs, CT will
not be as useful as MRI due to the less clear delineation of
the acute lesions. Also, whenever follow-ups are required,
in order to avoid excessive radiation doses being applied to
the patient, one might switch over to MRI which also helps
in improving final lesion volume assessment. Also, while
not yet playing a role in acute stroke management, hybrid
technologies such as PET-CT have a role for the workup of
patients with stroke who have a carotid stenosis as the
underlying cause. CT itself is in a constant flux of
development, and even more advanced methods such as
320 row detector CT units [60] or the advent of plat panel-
derived CT [61] will allow us to go faster, acquire more
tissular parameters and rendering acquisition, and evaluate
more easily without slowing down the pre-therapeutic
process.
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